EXEL
Exelixis, Inc.
Exelixis, Inc. is a biopharmaceutical company focused on developing cancer therapies, with a primary political signal being a single lobbying pattern linked to Rep. Ro Khanna (D-CA) on defense issues related to cancer drug access, despite $0 lobbying income reported in 2024.
Govt Dependence
30/100
Regulatory Density
85/100
Lobbying Intensity
10/100
Political Signal
NEUTRAL
BusinessWhat EXEL does
Exelixis is a biopharmaceutical company that discovers, develops, and commercializes targeted therapies for cancer treatment. Its revenue is primarily driven by sales of its flagship product, cabozantinib, marketed as CABOMETYX for various advanced cancers. The company also engages in partnerships and licensing agreements to expand its pipeline and commercial reach.
12 months past · 3 months futureEXEL activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
250 trading days ·
0 congressional trades shown
·
0 insider buys
·
0 13F filings
·
3 past bill actions
·
3 upcoming markups
Executive Branch ConflictsEXEL held by Trump-administration officials
1 cabinet/senior official reported EXEL positions in OGE Form 278 disclosures across 2 filings.
Lifetime Government AwardsEXEL federal contracts by year
$401K
total awarded · 2013–2016
39
contracts on file
2016
peak year ($221K)
Top contracts by award amount
$76K
Department of Veterans Affairs
2016-11-22
COMTRIQ 140MG
$21K
Department of Veterans Affairs
2016-05-16
CARBONZANTINIB
$21K
Department of Veterans Affairs
2016-03-23
EMERGENCY DRUG-COMETRIQ
$15K
Department of Veterans Affairs
2014-08-07
COMETRIQ
$14K
Department of Veterans Affairs
2015-01-21
COMETRIQ (60MG)
4 years · 39 contracts
Congressional TradesWho in Congress is trading EXEL
2024-01-10
Ro Khanna
Sale
$1,001 - $15,000
2024-01-10
Ro Khanna
sale
$1,001 - $15,000
2022-12-06
Ro Khanna
purchase
$1,001 - $15,000
2022-12-06
Ro Khanna
Purchase
$1,001 - $15,000
2019-01-09
(unknown)
Purchase
$1,001 - $15,000
474d late
2019-01-09
(unknown)
purchase
$1,001 - $15,000
474d late
2019-06-04
(unknown)
Sale
$1,001 - $15,000
328d late
2019-06-04
(unknown)
sale
$1,001 - $15,000
328d late
2019-02-06
(unknown)
purchase
$1,001 - $15,000
446d late
2019-04-16
(unknown)
sale
$1,001 - $15,000
377d late
2019-02-06
(unknown)
Purchase
$1,001 - $15,000
446d late
2019-04-16
(unknown)
Sale
$1,001 - $15,000
377d late
20+ trades on file · most recent 2024-02-05
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting EXELLive legislation impacting this stock
S.827 · 119th
Supporting Rural Veterans Access to Healthcare Services Act
HR.2001 · 119th
Action for Dental Health Act
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.2068 · 119th
Veterans Patient Advocacy Act
HR.2020 · 119th
New Mexico Rural Veteran Health Care Access Act
S.999 · 119th
Public Health Improvement Act
HR.2062 · 119th
To amend the Internal Revenue Code of 1986 to treat membership in a health care sharing ministry as a medical expense, and for oth
HR.2085 · 119th
Mental Health Research Accelerator Act of 2025
HR.2045 · 119th
Medicare Dental, Vision, and Hearing Benefit Act of 2025
HR.2048 · 119th
Metastatic Breast Cancer Access to Care Act
Political ProfileWhere EXEL sits in Washington
[object Object]
STRUCTURAL: Single lobbying pattern aligned with House Armed Services Committee on defense issues related to cancer drugs, but $0 lobbying income and no federal contracts. EVIDENTIARY: No corporate insider buys (tier F, 0 buys), no congressional traders, but executive branch exposure shows Trump holds EXEL stock and dividends. Net: Mixed signals with limited scale.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Potential changes to drug pricing, coverage, and payment under defense-related healthcare policiesDepartment of Defense, Centers for Medicare & Medicaid Services"get_political_influence.lobbying_patterns[0].committees includes HSAS (House Armed Services) and lobbying filings mention 'access, coverage, and payment for cancer drugs' under defense issue area."
Regulatory opportunities
-
Advocacy for improved access and coverage of cancer drugs through defense health programsDepartment of Defense"get_political_influence.lobbying_patterns[0].matches_committee true for HSAS, and lobbying filings focus on defense issues related to cancer drugs."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
LobbyingWho's hired to advocate for EXEL
ARNOLD & PORTER KAYE SCHOLER LLP defense
Member intelligence layer
Live signals + predictions for EXEL — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades EXEL
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout EXEL & political exposure
Does Exelixis, Inc. (EXEL) hold federal contracts?
Yes. Exelixis, Inc. has 39 federal contract awards totaling $400,504, primarily from agencies including Department of Veterans Affairs. See full contract list and amounts on this page.
Which Trump cabinet officials own EXEL stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in EXEL on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded EXEL stock?
20 congressional trades by 2 unique members of Congress, most recently on 2024-01-10. See the Congressional Trading panel for politician-by-politician breakdown.
What is EXEL political risk profile?
Government dependence: 30/100. Lobbying intensity: 10/100. Political signal: neutral. Donor party split: R 0% / D 100%.
How does GovGreed track EXEL political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. EXEL data is updated daily from these official federal sources.